Cited by 142Reproductive Health and ContraceptionHypothalamic control of reproductive hormonesReproductive Biology and Fertility

The DOI matches its Crossref record; 34 of the 37 references it cites were found in a registry or an index.

Ovarian function during use of a levonorgestrel-releasing IUD

Barbosa, Ione, Bakos, Oddvar, Olsson, Sven-Eric, Odlind, Viveca, Johansson, Elof D.B.·1990·Contraception

DOI 10.1016/0010-7824(90)90092-a

Open this paper in CoChat — free account

Abstract

Ovarian function was studied for two complete menstrual cycles in 9 regularly menstruating women and for 8 weeks in three amenorrhoeic women who had used levonorgestrel-releasing IUDs (LNG-IUD) for more than four years. Nine patients using copper IUDs (Nova-T) were studied for two complete menstrual cycles as controls. According to progesterone levels, 15/17 cycles in women using LNG-IUDs were ovulatory, whereas only 8/17 cycles showed normal follicular growth and rupture as judged by ultrasound. In ovulatory cycles, the peak progesterone levels were lower than in the controls. The preovulatory estradiol and LH peak levels were also lower than in control subjects. SHBG levels were lower in LNG-IUD users than in copper IUD users. It is concluded that, although the dose of levonorgestrel released from the IUD is very low, it probably exerts an effect on the gonadotrophin secretion, which disturbs follicular development in many of the women studied, which in addition to the local effect on the endometrium, contributes to its high contraceptive efficacy.

Integrity signals

Registry

Crossref · 10.1016/0010-7824(90)90092-a

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Beyond Family Planning
Berelson, B. (1969) · Science · doi:10.1126/science.163.3867.533 · Cited by 466
A Simplified Method for the Quantitative Determination of Testosterone-Estradiol-Binding Globulin Activity in Human Plasma
Rosner, W. (1972) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-34-6-983 · Cited by 347
Correlation of ultrasonic and endocrinologic assessment of human follicular development
Hackelöer, B.-J., Fleming, R., Robinson, H. P., Adam, A. H., & Coutts, J. R. T. (1979) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(79)80029-0 · Cited by 325
Radioimmunoassay of serum progesterone in women receiving oral contraceptive steroids
Thorneycroft, I. H., & Stone, S. C. (1972) · Contraception · doi:10.1016/0010-7824(72)90024-8 · Cited by 312
Long-Acting Contraceptive Delivery Systems
Zatuchni, G. I. (1985) · Studies in Family Planning · doi:10.2307/1965589 · Cited by 280
RADIOIMMUNOASSAY OF OESTRONE AND OESTRADIOL IN HUMAN AND BOVINE PERIPHERAL PLASMA
Edqvist, L.-E., & Johansson, E. D. B. (1972) · European Journal of Endocrinology · doi:10.1530/acta.0.0710716 · Cited by 197
Self-citation
Ovarian function in amenorrheic and menstruating users of a levonorgestrel-releasing intrauterine device
Nilsson, C. G., Lähteenmäki, P. L. A., & Luukkainen, T. (1984) · Fertility and Sterility · doi:10.1016/s0015-0282(16)47540-0 · Cited by 128
The effect of various dosages of lynestrenol on the plasma levels of oestrogens and progesterone during the menstrual cycle in the rhesus monkey
Bosu, W. T. K., Edqvist, L. ‐., Lindberg, P., Martinsson, K., & Johansson, E. D. B. (1976) · Contraception · doi:10.1016/0010-7824(76)90119-0 · Cited by 127
Self-citation
Radioimmunological Methods for the Estimation of Oestrone, Oestradiol 17β and Oestriol in Pregnancy Plasma
LINDBERG, B. S., Lindberg, P., Martinsson, Κ., & Johansson, E. D. B. (1974) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016347409156389 · Cited by 123
Self-citation
Plasma levels of d-norgestrel, estradiol and progesterone during treatment with silastic implants containing d-norgestrel
Weiner, E., & Johansson, E. D. B. (1976) · Contraception · doi:10.1016/s0010-7824(76)80011-x · Cited by 123
Self-citation

Show all 37 references

Research works printed but not linked: 1

Nilsson, 1981, Intrauterine contraception with levonorgestrel: A comparative randomized clinical performance study, Lancet, 1, 557

Sorted by citations

Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: A randomized comparative trial
Andersson, K. M., Odlind, V., & Rybo, G. (1994) · Contraception · doi:10.1016/0010-7824(94)90109-0 · Cited by 489
Self-citation
Strategies to prevent unintended pregnancy: increasing use of long-acting reversible contraception
Blumenthal, P. D., Voedisch, A. J., & Gemzell‐Danielsson, K. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq026 · Cited by 290
Copper-T intrauterine device and levonorgestrel intrauterine system: biological bases of their mechanism of action
Ortiz, M. E., & Croxatto, H. B. (2007) · Contraception · doi:10.1016/j.contraception.2007.01.020 · Cited by 244
Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years
Hidalgo, M., Bahamondes, L. G., Perrotti, M. A., Dı́az, J., Monteiro-Dantas, C., & Petta, C. A. (2002) · Contraception · doi:10.1016/s0010-7824(01)00302-x · Cited by 235
Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding
Crosignani, P., Vercellini, P., Mosconi, P., OLDANI, S., Cortesi, I., & DEGIORGI, O. (1997) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(97)00226-3 · Cited by 227
Contraceptive use and behavior in the 21st century: a comprehensive study across five European countries
Skouby, S. O. (2010) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625187.2010.533002 · Cited by 221
Contraceptive use and behavior in the 21st century: a comprehensive study across five European countries
Skouby, S. O. (2004) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625180410001715681 · Cited by 163
Transvaginal sonographic ovarian findings in a random sample of women 25–40 years old
Borgfeldt, C., & Andolf, E. G. (1999) · Ultrasound in Obstetrics and Gynecology · doi:10.1046/j.1469-0705.1999.13050345.x · Cited by 158
Return to fertility after removal of a levonorgestrel-releasing intrauterine device and Nova-T
Andersson, K. M., Batár, I., & Rybo, G. (1992) · Contraception · doi:10.1016/0010-7824(92)90122-a · Cited by 137
Pregnancy during the use of levonorgestrel intrauterine system
Backman, T., Rauramo, I., Huhtala, S., & Koskenvuo, M. J. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2003.07.021 · Cited by 133
Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties
Luukkainen, T., & Toivonen, J. (1995) · Contraception · doi:10.1016/0010-7824(95)00210-2 · Cited by 132
Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system
Suvisaari, J. V. J., & Lähteenmäki, P. (1996) · Contraception · doi:10.1016/s0010-7824(96)00189-8 · Cited by 123
Pharmacokinetics of two low-dose levonorgestrel-releasing intrauterine systems and effects on ovulation rate and cervical function: pooled analyses of phase II and III studies
Apter, D. L., Gemzell‐Danielsson, K., Hauck, B., Rosén, K., & Zurth, C. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.03.004 · Cited by 109
Ultrasound evaluation of ovarian activity under oral contraceptives
Hoogland, H. J., & Skouby, S. O. (1993) · Contraception · doi:10.1016/0010-7824(93)90025-3 · Cited by 103
Canadian Contraception Consensus (Part 3 of 4): Chapter 7 – Intrauterine Contraception
Black, A., Guilbert, É., Costescu, D., Dunn, S., Fisher, W. A., Kives, S. L., Mirosh, M., Norman, W. V., Pymar, H. C., Reid, R. L., et al. (2016) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2015.12.002 · Cited by 89
Therapeutic effects of the levonorgestrel-releasing intrauterine system in the treatment of idiopathic menorrhagia
Bilian, X., Wu, S., Chong, J., Zeng, T., Han, L. I.-H., & Luukkainen, T. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(02)04913-0 · Cited by 88
The levonorgestrel intrauterine system in contraception
Lähteenmäki, P. L. A. (2000) · Steroids · doi:10.1016/s0039-128x(00)00176-8 · Cited by 86
Ovarian function after seven years' use of a levonorgestrel IUD
Barbosa, I. C., Olsson, S., Odlind, V., Goncalves, T., & Coutinho, E. M. (1995) · Advances in Contraception · doi:10.1007/bf01987274 · Cited by 86
Self-citation
Levonorgestrel
Fotherby, K. (1995) · Clinical Pharmacokinetics · doi:10.2165/00003088-199528030-00003 · Cited by 81
Comparison of ovarian cyst formation in women using the levonorgestrel‐releasing intrauterine system vs. hysterectomy
Inki, P., Hurskainen, R., Palo, P., Ekholm, E. M. K., Grénman, S., Kivelä, A., Kujansuu, E., Teperi, J., Yliskoski, M. H., & Paavonen, J. A. (2002) · Ultrasound in Obstetrics and Gynecology · doi:10.1046/j.1469-0705.2002.00805.x · Cited by 78
Effects of the levonorgestrel-releasing intrauterine system on cervical mucus quality and sperm penetrability
Lewis, R. A., Taylor, D., Natavio, M. F. Q., Melamed, A., Felix, J. C., & Mishell, D. R. (2010) · Contraception · doi:10.1016/j.contraception.2010.06.006 · Cited by 77
Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use
Bilian, X., Zeng, T., Wu, S., Sun, H., & Xiao, N. (1995) · Contraception · doi:10.1016/0010-7824(95)00102-g · Cited by 77
The effect of a levonorgestrel-releasing intrauterine system on uterine artery blood flow, hormone concentrations and ovarian cyst formation in fertile women
Jarvela, I., Tekay, A., & Jouppila, P. I. (1998) · Human Reproduction · doi:10.1093/humrep/13.12.3379 · Cited by 77
Residual ovarian activity during oral steroid contraception
van Heusden, A. M. (2002) · Human Reproduction Update · doi:10.1093/humupd/8.4.345 · Cited by 71
Induction and Maintenance of Amenorrhea in Transmasculine and Nonbinary Adolescents
Carswell, J. M., & Roberts, S. A. (2017) · Transgender Health · doi:10.1089/trgh.2017.0021 · Cited by 70
Role of progestins in contraception
Erkkola, R., & Landgren, B. (2005) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1080/j.0001-6349.2005.00759.x · Cited by 70
A risk-benefit assessment of the levonorgestrel-releasing intrauterine system
Sturridge, F., & Guillebaud, J. (1996) · Drug Safety · doi:10.2165/00002018-199615060-00006 · Cited by 69
Safety, efficacy and patient acceptability of the contraceptive and non-contraceptive uses of the LNG-IUS
Jensen, J. T. (2009) · International Journal of Women s Health · doi:10.2147/ijwh.s4350 · Cited by 69
A randomized controlled trial of hysterectomy or levonorgestrel-releasing intrauterine system in the treatment of menorrhagia--effect on FSH levels and menopausal symptoms
Halmesmäki, K. H. (2004) · Human Reproduction · doi:10.1093/humrep/deh055 · Cited by 64
Clinical profile of contraceptive progestins
Benagiano, G., Primiero, F. M., & Farris, M. (2004) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625180400007736 · Cited by 63
The benefits and risks of using a levonorgestrel-releasing intrauterine system for contraception
Mansour, D. (2011) · Contraception · doi:10.1016/j.contraception.2011.08.003 · Cited by 64
Benefit-Risk Assessment of the Levonorgestrel Intrauterine System in Contraception
Backman, T. (2004) · Drug Safety · doi:10.2165/00002018-200427150-00003 · Cited by 62
Effects of various iuds on the composition of cervical mucus
Jonsson, B., Landgren, B.-M., & Eneroth, P. H. E. (1991) · Contraception · doi:10.1016/0010-7824(91)90135-3 · Cited by 62
The levonorgestrel-releasing intrauterine system (LNG-IUS) in HIV-infected women—effects on bleeding patterns, ovarian function and genital shedding of HIV
Heikinheimo, O., Lehtovirta, P., Suni, J. I., & Paavonen, J. A. (2006) · Human Reproduction · doi:10.1093/humrep/del264 · Cited by 60
Cervical mucus and contraception: what we know and what we don't
Han, L. L., Taub, R., & Jensen, J. T. (2017) · Contraception · doi:10.1016/j.contraception.2017.07.168 · Cited by 59
Oral and depot progestin therapy for endometriosis: towards a personalized medicine
Buggio, L., Somigliana, E., Barbara, G., Frattaruolo, M. P., & Vercellini, P. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1381086 · Cited by 58
The effect of hysterectomy or levonorgestrel‐releasing intrauterine system on sexual functioning among women with menorrhagia: a 5‐year randomised controlled trial
Halmesmäki, K. H., Hurskainen, R., Teperi, J., Grénman, S., Kivelä, A., Kujansuu, E., Tuppurainen, M., Yliskoski, M. H., Vuorma, S., & Paavonen, J. A. (2007) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2007.01306.x · Cited by 53
FFPRHC Guidance (April 2004): The levonorgestrel-releasing intrauterine system (LNG-IUS) in contraception and reproductive health
(2004) · Journal of Family Planning and Reproductive Health Care · doi:10.1783/147118904322995474 · Cited by 53
Cost-utility of levonorgestrel intrauterine system compared with hysterectomy and second generation endometrial ablative techniques in managing patients with menorrhagia in the UK
Clegg, J. P., Guest, J. F., & Hurskainen, R. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x199709 · Cited by 48
Intrauterine devices
Bilian, X. (2002) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1053/beog.2002.0267 · Cited by 47
A Latin American Experience with Levonorgestrel IUD
Faúndes, A., Alvarez, F., & Díaz, J. (1993) · Annals of Medicine · doi:10.3109/07853899309164159 · Cited by 43
Contraception Today
Benagiano, G., Bastianelli, C., & Farris, M. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1365.002 · Cited by 40
Effects of levonorgestrel-releasing intra-uterine system on the expression of vascular endothelial growth factor and adrenomedullin in the endometrium in adenomyosis
Laoag‐Fernandez, J. B. (2003) · Human Reproduction · doi:10.1093/humrep/deg179 · Cited by 39
The endometrium and hormonal contraceptives
Benagiano, G., Pera, A., & Primiero, F. M. (2000) · Human Reproduction · doi:10.1093/humrep/15.suppl_1.101 · Cited by 39
FSRH Guideline (March 2023) Intrauterine contraception
British Medical Journal Publishing Group (2023) · BMJ Sexual & Reproductive Health · doi:10.1136/bmjsrh-2023-iuc · Cited by 36
Experience with the levonorgestrel-releasing intrauterine system among HIV-infected women
Lehtovirta, P., Paavonen, J. A., & Heikinheimo, O. (2006) · Contraception · doi:10.1016/j.contraception.2006.09.006 · Cited by 36
mRNA expression of insulin-like growth factor-I (IGF-I) is suppressed and those of IGF-II and IGF-binding protein-1 are constantly expressed in the endometrium during use of an intrauterine levonorgestrel system
Rutanen, E. ‐. (1997) · Molecular Human Reproduction · doi:10.1093/molehr/3.9.749 · Cited by 35
Long-Acting Hormonal Contraception
Benagiano, G., Gabelnick, H. L., & Brosens, I. A. (2015) · Women s Health · doi:10.2217/whe.15.68 · Cited by 34
Canadian Contraception Consensus
(2004) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)30260-2 · Cited by 33
Usage of the levonorgestrel-releasing intrauterine system (LNG-IUS) in adolescence: what is the evidence so far?
Patseadou, M., & Michala, L. (2016) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-016-4261-0 · Cited by 33
Effect of hysterectomy or LNG-IUS on serum inhibin B levels and ovarian blood flow
Halmesmäki, K. H., Hurskainen, R., Cacciatore, B., Tiitinen, A. E., & Paavonen, J. A. (2007) · Maturitas · doi:10.1016/j.maturitas.2007.01.007 · Cited by 31
Treatment of menorrhagia with an LNG-IUS
Pakarinen, P. I., & Luukkainen, T. (2007) · Contraception · doi:10.1016/j.contraception.2007.01.008 · Cited by 30
Levonorgestrel‐releasing intrauterine system for treating menstrual disorders: A patient satisfaction questionnaire
RADESIC, B., & Sharma, A. (2004) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2004.00206.x · Cited by 28
The effect of intrauterine and oral levonorgestrel administration on serum concentrations of sex hormone-binding globulin, insulin and insulin-like growth factor binding protein-1
Pakarinen, P. I., Lähteenmäki, P., & Rutanen, E. (1999) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1080/j.1600-0412.1999.780515.x · Cited by 29
Randomized placebo-controlled trial of CDB-2914 in new users of a levonorgestrel-releasing intrauterine system shows only short-lived amelioration of unscheduled bleeding
Warner, P., Guttinger, A., Glasier, A. F., Lee, R. J., Nickerson, S., Brenner, R., & Critchley, H. (2009) · Human Reproduction · doi:10.1093/humrep/dep377 · Cited by 28
NEW CONTRACEPTIVE METHODS
Grow, D. R., & Ahmed, S. (2000) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70176-5 · Cited by 28
Gynaecological aspects of the levonorgestrel‐releasing intrauterine system
Sturridge, F., & Guillebaud, J. (1997) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1997.tb11455.x · Cited by 27
Contraceptive devices: intravaginal and intrauterine delivery systems
Benagiano, G., Gabelnick, H. L., & Farris, M. (2008) · Expert Review of Medical Devices · doi:10.1586/17434440.5.5.639 · Cited by 25
Morphometric studies of the endometrium, the Fallopian tube and the corpus luteum during contraception with the 300 μg norethisterone (NET) minipill
Kim-Björklund, T., Landgren, B.-M., & JOHANNISSON, E. (1991) · Contraception · doi:10.1016/0010-7824(91)90136-4 · Cited by 25
Levonorgestrel-Releasing Intrauterine System for the Treatment of Endometriosis: Biological and Clinical Evidence
Viganò, P., Somigliana, E., & Vercellini, P. (2007) · Women's Health · doi:10.2217/17455057.3.2.207 · Cited by 23
Menstrual Suppression for Adolescents with Developmental Disabilities
Savasi, I., Spitzer, R. F., Allen, L. M., & Ornstein, M. P. (2009) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2007.10.008 · Cited by 22
Long-term experience of a levonorgestrel-releasing intrauterine system
Odlind, V. (1996) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625189609150677 · Cited by 22
Self-citation
Hormonal Intrauterine Devices
Rybo, G., Andersson, K. M., & Odlind, V. (1993) · Annals of Medicine · doi:10.3109/07853899309164158 · Cited by 22
Self-citation
IUDs: Which device?
Dennis, J., & Hampton, N. (2002) · Journal of Family Planning and Reproductive Health Care · doi:10.1783/147118902101196199 · Cited by 20
Assessment of the quality of cervical mucus among users of the levonorgestrel-releasing intrauterine system at different times of use
Moraes, L. G., Marchi, N. M., Pitoli, A. C., Hidalgo, M. M., da Silveira, C. C., Modesto, W., & Bahamondes, L. G. (2016) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625187.2016.1193139 · Cited by 19
Recent advances in hormonal contraception
Erkkola, R. (2007) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e3282f1e7b6 · Cited by 19
Hair loss with use of the levonorgestrel intrauterine device
Paterson, H., Clifton, J., Miller, D., Ashton, J., & Harrison‐Woolrych, M. (2007) · Contraception · doi:10.1016/j.contraception.2007.06.015 · Cited by 19
Effects of a single contraceptive Silastic implant containing nomegestrol acetate on ovarian function and cervical mucus production during 2 years
Barbosa, I., Coutinho, E. M., Hirsch, C., Ladipo, O. A., Olsson, S., & Ulmsten, U. (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58204-1 · Cited by 19
Self-citation
Successful Pregnancy following Insertion of a Levonorgestrel-Releasing Intrauterine System in Two Infertile Patients with Complex Atypical Endometrial Hyperplasia
Qi, X., Zhao, W., Duan, Y., & Li, Y. (2008) · Gynecologic and Obstetric Investigation · doi:10.1159/000113308 · Cited by 16
A morphometric study on the endometrial activity of women before and after one year with LNG-IUD in situ
Gu, Z., Zhu, P., Luo, H., Zhu, X., Zhang, G., & Wu, S. (1995) · Contraception · doi:10.1016/0010-7824(95)00125-t · Cited by 16
Hormonal Management of Abnormal Uterine Bleeding
Singh, R. H., & Blumenthal, P. D. (2005) · Clinical Obstetrics & Gynecology · doi:10.1097/01.grf.0000159540.11974.17 · Cited by 15
Temporal relationship between uniplant insertion and changes in cervical mucus
Barbosa, I., Coutinho, E. M., Hirsch, C., Ladipo, O. A., Olsson, S. E., & Ulmsten, U. (1996) · Contraception · doi:10.1016/s0010-7824(96)00191-6 · Cited by 15
Self-citation
Novel delivery systems in contraception
Lähteenmäki, P. L. A., & Jukarainen, H. (2000) · British Medical Bulletin · doi:10.1258/0007142001903328 · Cited by 15
The Levonorgestrel‐Releasing Intrauterine Device: A Wider Role Than Contraception
Coleman, M., McCowan, L. M. E., & Farquhar, C. M. (1997) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.1997.tb02253.x · Cited by 14
Effects of a single Silastic® contraceptive implant containing nomegestrol acetate (Uniplant) on endometrial morphology and ovarian function for 1 year
Barbosa, I., Maia, H., Coutinho, E. M., Lopes, R. C., Lopes, A. C. V., Noronha, C. F., & Botto, A. (2006) · Contraception · doi:10.1016/j.contraception.2006.07.013 · Cited by 13
Self-citation
The levonorgestrel-releasing intrauterine device is related to early emotional reactivity: An ERP study
Zelionkaitė, I., Gaižauskaitė, R., Uusberg, H., Uusberg, A., Ambrasė, A., Derntl, B., & Grikšienė, R. (2024) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2023.106954 · Cited by 12
Striatal dopamine synthesis and cognitive flexibility differ between hormonal contraceptive users and nonusers
Taylor, C. M., Furman, D. J., Berry, A. S., White, R. L., Jagust, W. J., D’Esposito, M., & Jacobs, E. G. (2023) · Cerebral Cortex · doi:10.1093/cercor/bhad134 · Cited by 12
Successful twin pregnancy achieved by assisted reproductive technology in a patient with polycystic ovary syndrome with complex atypical endometrial hyperplasia treated with levonorgestrel-releasing intrauterine system
Ercan, C. M., Duru, N. K., Sakıncı, M., Alanbay, İ., Karaşahin, K. E., & Başer, İ. (2010) · Gynecological Endocrinology · doi:10.3109/09513590903015569 · Cited by 11
Sex hormone binding globulin and free levonorgestrel index in the first week after insertion of Norplant® implants
Alvarez, F., Brache, V., Tejada, A.-S., Cochón, L., & Faúndes, A. (1998) · Contraception · doi:10.1016/s0010-7824(98)00102-4 · Cited by 11
The Levonorgestrel-Releasing Intrauterine Device as Emergency Contraception
Ramanadhan, S., & Jensen, J. T. (2023) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000005466 · Cited by 10
Two Years Follow-Up of Patients with Abnormal Uterine Bleeding after Insertion of the Levonorgestrel-Releasing Intrauterine System
Çim, N., Soysal, S., Sayan, S., Yıldızhan, B., Karaman, E., Çetin, O., Tolunay, H. E., & Yıldızhan, R. (2017) · Gynecologic and Obstetric Investigation · doi:10.1159/000480012 · Cited by 10
Randomized controlled trial of the effect of hysterectomy or LNG-IUS use on bone mineral density: a five-year follow-up
Halmesmäki, K. H., Paavonen, J. A., Tuppurainen, M. T., & Hurskainen, R. (2006) · Therapy · doi:10.1586/14750708.3.4.509 · Cited by 10
The Pathology of Intra-Uterine Contraceptive Devices
BUCKLEY, C. H. (1994) · Current topics in pathology · doi:10.1007/978-3-642-76846-0_8 · Cited by 10
Impact of Combined Hormonal Contraceptive Use on Weight Loss: A Secondary Analysis of a Behavioral Weight‐Loss Trial
Caldwell, A. E., Zaman, A., Ostendorf, D. M., Pan, Z., Swanson, B., Phelan, S., Wyatt, H. R., Bessesen, D. H., Melanson, E. L., & Catenacci, V. A. (2020) · Obesity · doi:10.1002/oby.22787 · Cited by 9
Free levonorgestrel index and its relationship with luteal activity during long-term use of Norplant implants
Brache, V., Alvarez‐Sánchez, F., Faúndes, A., Tejada, A. S., & Cochón, L. (1992) · Advances in Contraception · doi:10.1007/bf02042590 · Cited by 9
4 Modern intra-uterine devices
Odlind, V. (1996) · Baillière s Clinical Obstetrics and Gynaecology · doi:10.1016/s0950-3552(96)80062-9 · Cited by 9
Self-citation
A Novel Microbicide/Contraceptive Intravaginal Ring Protects Macaque Genital Mucosa against SHIV-RT Infection Ex Vivo
Villegas, G., Calenda, G., Ugaonkar, S. R., Zhang, S., Kizima, L., Mizenina, O. A., Gettie, A., Blanchard, J., Cooney, M. L., Robbiani, M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159332 · Cited by 8
NORPLANT and the Levonorgestrel IUD in Chinese Family Planning Programmes
Bilian, X., Sujuan, G., Shu-li, W., Zhu, P., & Shi, S.-Q. (1993) · Annals of Medicine · doi:10.3109/07853899309164161 · Cited by 8
Current assessment of the use of intrauterine devices
Westhoff, C. L. (1996) · Journal of Nurse-Midwifery · doi:10.1016/0091-2182(96)00015-8 · Cited by 7
Androgen levels in women using a single implant of nomegestrol acetate
Barbosa, I., Coutinho, E. M., Athayde, C., Ladipo, O. A., Olsson, S., & Ulmsten, U. (1996) · Contraception · doi:10.1016/0010-7824(95)00256-1 · Cited by 7
Self-citation
Contraceptive strategies for young women in the 21st century
Ruusuvaara, L., & Johansson, E. D. B. (1999) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625189909071346 · Cited by 6
Self-citation
A review of the effects of long-acting progestogen-only contraceptives on ovarian activity
Li, X. F., Davies, G. C., & Newton, R. (1992) · Advances in Contraception · doi:10.1007/bf01849342 · Cited by 6
Adrenocorticotropic hormone elicits gonadotropin secretion in premenopausal women
Aleknavičiūtė, J., Tulen, J. H. M., Timmermans, M., de Rijke, Y. B., van Rossum, E. F. C., de Jong, F. H., & Kushner, S. A. (2016) · Human Reproduction · doi:10.1093/humrep/dew190 · Cited by 5
Ultrasonographic monitoring of ovarian follicles in women using norethisterone for contraception
Chitlange, S., Shah, R., Hazari, K. T., Anandkumar, T. C., & Puri, C. P. (1996) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(95)02610-x · Cited by 5
Consensus canadien sur la contraception
(2004) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)30261-4 · Cited by 4
Levonorgestrel-releasing intrauterine system for menstrual dysfunction: patient satisfaction in the district general hospital setting
Macnab, J. L., & Lowles, I. E. (2002) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443610220141371 · Cited by 4
Intrauterine contraception: an update
Bhathena, R. K., & Guillebaud, J. (2008) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443610802042266 · Cited by 3
Intrauterine progestogens for management of menorrhagia
Kulatunga, S., & Fraser, I. S. (1998) · Current Obstetrics and Gynaecology · doi:10.1016/s0957-5847(98)80019-x · Cited by 3
Serum levonorgestrel concentration and cervical mucus viscosity after six months of monoplant® implantation
Gunardi, E. R., & Affandi, B. (2014) · Medical Journal of Indonesia · doi:10.13181/mji.v23i1.685 · Cited by 3
Managing persistent ovarian follicles in premenopausal women fitted with the levonorgestrel‐releasing intrauterine system
Morelli, M., Cello, A. D., & Zullo, F. (2012) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2012.09.008 · Cited by 3

Authors: Barbosa, I., Bakos, O., Olsson, S.-E., Odlind, V., & Johansson, E. D. B.
Affiliations: Uppsala University (SE)
Venue: Contraception
Publisher: Elsevier BV
Published: 1990-07
Volume: 42
Issue: 1
Pages: 51-66
ISSN: 0010-7824 (ISSN-L)
DOI: 10.1016/0010-7824(90)90092-a
OpenAlex: W2138771402
Cited by: 142
References: 37
Citations by year: 2026: 2 · 2025: 2 · 2024: 2 · 2023: 3 · 2022: 7 · 2021: 1 · 2020: 2 · 2019: 1 · 2017: 5 · 2016: 5 · 2015: 2 · 2014: 2 · 2013: 2 · 2012: 3
FWCI: 4.84
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Contraception (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
Keywords: levonorgestrel-releasing IUD, ovarian function, ovulation, progesterone, folliculogenesis, gonadotropin secretion, luteinizing hormone, estradiol, sex hormone-binding globulin, copper intrauterine device, amenorrhea, contraceptive efficacy
MeSH terms: Adult, Cervix Mucus, Contraceptive Agents, Female, Endometrium, Estradiol, Female, Follicular Cyst, Gonadotropins, Humans, Intrauterine Devices, Copper, Intrauterine Devices, Medicated, Luteinizing Hormone, Male, Norgestrel, Ovary, Progesterone, Sex Hormone-Binding Globulin, Sperm-Ovum Interactions, Ultrasonography, Levonorgestrel

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Ovarian function during use of a levonorgestrel-releasing IUD

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks